According to study by Future Market Insights, the Global Clinical Chemistry Enzymes Market is anticipated to expand at a CAGR of 5.9% over the forecasted time period. By 2033, the market value is expected to have grown from US$ 3.2 billion to US$ 5.7 billion. At the end of 2022, the market for clinical chemistry enzymes was valued at US$ 3.1 billion, and in 2023, it is expected to rise by 5.3% year over year.
The clinical chemistry enzymes market plays a vital role in the field of clinical diagnostics, facilitating the measurement of various analytes for disease diagnosis, monitoring, and research purposes.
The rising global burden of chronic diseases such as diabetes, cardiovascular diseases, and cancer has led to an increased demand for clinical chemistry testing. Enzymes are crucial components in diagnostic assays for measuring biomarkers associated with these diseases, contributing to market growth.
Open the gateway to innovation and prosperity by downloading our exclusive Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-17807
The shift toward personalized medicine has increased the need for precise and reliable diagnostic tests. Clinical chemistry enzymes play a crucial role in measuring specific biomarkers for personalized treatment decisions. The demand for personalized medicine and targeted therapies has contributed to the growth of the clinical chemistry enzymes market.
Key players in the clinical chemistry enzymes market often engage in strategic collaborations, partnerships, and acquisitions to enhance their product portfolios, expand their market presence, and develop innovative enzyme solutions. These collaborations contribute to the overall market growth.
Key Takeaways from Market Study
- By enzyme type, acid phosphatase – ACP accounts for US$ 411.8 million in 2022. Acid phosphatase is commonly used as a biomarker to assess prostate health.
- By application, diagnostics purpose accounts for US$ 2.0 Billion in 2022. Clinical chemistry enzymes are essential biomarkers used for the early detection and diagnosis of various diseases and medical conditions
- Hospitals held more than 35.6% of the global market share in 2022. Hospitals handle a large volume of patients for diagnostic testing on a daily basis
- By region, North America held dominant share in world in 2022. The increasing frequency of various liver illnesses will drive market expansion in North America.
“The increasing prevalence of chronic illness and increase in adoption rate of laboratory tests contribute to global expansion.” says an analyst of Future Market Insights.
Market Competition:
The clinical chemistry enzymes market is highly competitive, with key players including Thermo Fisher Scientific. These companies are constantly participating conferences, award competition with their products and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.
- In September 2021, Thermo Fisher Scientific has announced the availability of their fully automated analyzers, which are intended primarily for applications involving enzyme assays.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the clinical chemistry enzymes market in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global clinical chemistry enzymes market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader
The analysis is based on enzyme type (acid phosphatase – ACP, alanine amino-transferase – ALT/GPT, alkaline phosphatase – ALP, aspartate amino-transferase – AST/GOT, cholinesterase – CHE, creatine kinase – CK, creatine kinase MB – CK-MB, gamma glutamyltransferase – GGT, glutamate dehydrogenase – GLDH, hydroxybutyrate dehydrogenase – HBDH, lactate dehydrogenase – LDH, lipase – LIP), by application (diagnostics purpose, therapeutic purpose, and analytical purpose), and by end user (hospitals, diagnostics/pathology labs, ambulatory surgical centers, and others), across seven key regions around the world.
Key Companies Profiled:
- Takara Bio, Inc.
- Promega Corporation
- Enzo Life Sciences, Inc.
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Creative Enzyme
- F. Hoffmann-La Roche Ltd.
- Solis BioDyne.
- Ambliqon A/S.
- ekf Diagnostics
- Abbot
- Sekisui Diagnostics
- Aldevron
- Codexis Inc.
Key Market Segments Covered in the Clinical Chemistry Enzymes Industry Research
By Enzyme Type:
- Acid Phosphatase – ACP
- Alanine Amino-Transferase – ALT/GPT
- Alkaline Phosphatase – ALP
- Aspartate Amino-Transferase – AST/GOT
- Cholinesterase – CHE
- Creatine Kinase – CK
- Creatine Kinase MB – CK-MB
- Gamma Glutamyltransferase – GGT
- Glutamate Dehydrogenase – GLDH
- Hydroxybutyrate Dehydrogenase – HBDH
- Lactate Dehydrogenase – LDH
- Lipase – LIP
By Application:
- Diagnostics Purpose
- Therapeutic Purpose
- Analytical purpose
By End User:
- Hospitals
- Diagnostics/Pathology Labs
- Ambulatory Surgical Centers
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
